Classes of antimicrobial agents
-
Upload
dr-geoffrey-maiyoh -
Category
Health & Medicine
-
view
129 -
download
1
Transcript of Classes of antimicrobial agents
MBSM 713: BIOCHEMISTRY OF ANTI MICROBIAL AGENTS
Lecture Two:
Survey of major antimicrobial drug groups
1.ANTIBACTERIAL AGENTS(Antibiotics)
Dr. G. Kattam Maiyoh
01/23/15 1
GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
01/23/15 4GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Bacterial cell wall• There are three types
– Gram-positive (e.g. Staphylococci, Listeria
• Have many peptidoglycan layers
• stains with crystal violet• typically lack the outer
membrane found in gram-ve.
– Gram-negative (e.g. E.coli, Salmonella)
• Have few peptidoglycan layers• (stain safranin or fuchsin)
– Acid-fast Positive (Mycobacteria)• Cell wall contains waxy
substance (Mycollic acid)• Stains with acid fast (heating
required)
Antibiotics - Cell wall synthesis inhibitors
Beta-lactam antibiotics:
1928 - Alexander Fleming observes the antibacterial effects of Penicillin
1940 - Florey and Chain extract Penicillin
01/23/15 5GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
The beta lactams• The β-lactam group of antibiotics
includes an enormous diversity of natural and semi-synthetic compounds that inhibit several enzymes associated with the final step of peptidoglycan synthesis.
• All of this enormous family are derived from a β -lactam structure: a four-membered ring in which the β -lactam bond resembles a peptide bond.
• The multitude of chemical modifications based on this four-membered ring permits the astonishing array of antibacterial and pharmacological properties within this valuable family of antibiotics.
01/23/15 6GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
The Beta-Lactams
01/23/15GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC027
R – variable side chain
Monobactam nucleus
Penicillinase (β Lactamase)
- Represents a great challenge to the action of the beta lactams
Figure 20.8
More when we discuss antibiotic resistance
01/23/15 8GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
• Penicillium notatum produces the only naturally occurring agent – penicillin G or benzylpenicillin
• Penicillium chrysogenum produces 6-aminopenicillanic acid, raw material for semi-synthetics penicillins
01/23/15 9GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Targets for beta lactams1. The targets for β-lactam drugs are the penicillin binding
proteins (PBP's), so called because they bind radioactive penicillin and can be detected by autoradiography of gels on which bacterial proteins have been separated electrophoretically.
• The penicillin binding proteins have transpeptidase or carboxypeptidase activity and they act to regulate cell size and shape.
• They are also involved in septum formation and cell division. Bacteria have several individual penicillin binding proteins, each with a separate function.
• Conventionally these are numbered according to size, with PBP 1 as the largest protein.
• The PBP 1 of one bacterium will not necessarily have the same function as the PBP 1 of a different organism.
01/23/15 10GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Target2. The β-lactam antibiotics also stimulate the activity of autolysins by inactivating an inhibitor => lysis
• Autolysins are enzymes that are responsible for the natural turnover of cell wall polymers to permit growth of the cells.
• Under normal conditions, these enzymes produce controlled weak points within the peptidoglycan structure to allow for expansion of the cell wall structure.
• This activity is stimulated by β-lactams, causing a breakdown of peptidoglycan and leading to osmotic fragility of the cell and ultimately to cell lysis.
01/23/15 11GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Penicillins - classification– Narrow spectrum – penicillinase sensitive
– Narrow spectrum – penicillinase resistant
– Broad spectrum penicillins
– Extended-spectrum penicillins• Cephalosporines
• Carbapenems
• Monobactams
• Vancomycin, Bacitracin
01/23/15 12GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Penicllins (pharmacokinetics)
• Attains therapeutic concentration in most tissues
• However has poor CSF penetration• Renal excretion (Excretion)• Side effects: hypersensitivity, nephritis,
neruotoxicity, platelet dysfunction
01/23/15 14GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Narrow spectrum – penicillinase (= β-lactamase) sensitive• Benzylpenicillin
– Naturally occuring
– Poor oral availability (sensitive to stomach acid)
=> given by injection
– Active against gram-positive bacteria
• Phenoxymethylpenicillin
– Better oral availability (acid resistant)
01/23/15 15GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Narrow spectrum – penicillinase (= β-lactamase) resistant• Methicillin
– Semisynthetic– Poor oral availability (only parenteral)– Active against gram-pos bacteria– Mostly used for Staphylococcus aureus
• Oxacillin– Good oral availability
• Cloxacillin• Dicloxacillin
01/23/15 16GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Broad spectrum – penicillinase (β-lactamase) sensitive
(Also referred to as Aminopenicillins)
• Ampicillin– Semisynthetic
– Good oral availability
– Active against gram-pos and gram-neg bacteria
– Active against enterobacteria e.g. kleb. Shig. Salm
• Amoxicillin
– Excellent oral availability
01/23/15 17GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Extended spectrum – penicillinase (β-lactamase) sensitive
(Also called Carboxypenicillins)
• Carbenicillin– Semisynthetic– Poor oral availability– Active against gram-pos and gram-neg bacteria– Active against Pseudomonas aeruginosa and
Klebsiella
• Ticarcillin• Mezlocillin• Pipercillin
01/23/15 18GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Cephalosporins• Share the same antibiotic mechanism as penicillins• Cross-allergies with penicillins are common• Some CSs antagonize Vitamin K => leads to bleeding• Some CSs block alcohol oxidation => disulfiram effect (allergic
reactions, seizures, extreme tiredness and dark urine)
Classified into generations: 1- 4 • Increasing activity against gram-negative bacteria and
anaerobes• Increasing resistance to destruction by beta-lactamases• Increasing ability to reach cerebrospinal fluid
01/23/15 21GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Cephalosporins
• The first to be discoverded were called first generation while later, more extended spectrum cephalosporins were classified as second, third and 4th generation cephalosporins in this order.
• Each newer generation has significantly greater gram-negative antimicrobial properties than the preceding generation,
• Most cases with decreased activity against gram-positive organisms.
• Fourth generation cephalosporins, however, have true broad spectrum activity.
01/23/15 22GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
• Base molecule is 7-aminocephalosporanic acid produced by a Sardinian sewer mold
• R groups determine spectrum of activity and pharmacological properties
• Mechanism of action/resistance and class pharmacology is essentially the same as penicillins
01/23/15 25GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
First Generation Cephalosporins
• Cefazolin, cephalexin, cephadroxil
• Excellent against susceptible staph and strep
• Modest activity against G -ve• Cefazolin given parentally,
others orally• More than half of the drug is
bound to plasma proteins• Excreted by kidneys
unmetabolized• Good for staph and strep skin
and soft tissue infections
01/23/15 26GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Second Generation Cephalosporins• Include;– Cefaclor,– cefuroxime, – cefprozil
• Modest activity against G+, increased activity against G-, works against anaerobes
• Cefaclor and cefprozil given orally• Absorption and excretion same as first
generation.• Good for treating respiratory tract infections,
intra-abdominal infections, pelvic inflammatory disease, diabetic foot ulcers
01/23/15 27GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Third Generation Cephalosporins• Ceftaxime, ceftriaxzone,
cefoperazone, cefpodoxime• Broad spectrum killers• Drugs of choice for serious
infections• No effect against Listeria and beta-
lactamase producing pneumococci• Cefpodoxime given orally, others
parentally• Most excreted by kidney• Therapeutic uses – Bacterial meningitis– Lyme disease– Life-threatening G -ve sepsis
(infection)
01/23/15 28GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Fourth Generation Cephalosporin
– e.g.Cefepime
–Have true broad spectrum activity ( and more beta-lactamases resistanc (effective against Gm+ and Gm-)
–Given parentally, excellent penetration into CSF
–Good for nosocomial infections
01/23/15 29GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications of Cephalosporins
• Hypersensitivity reactions (uncommon) essentially same as for penicillins
• Cross-reaction between 2 classes
01/23/15 31GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Carbapenems
• Beta-lactam ring is fused to a 5 member ring system
• Effect on microbes and pharmacology of carbapenems similar to penicillins
01/23/15 34GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Selected Carbapenems• Imipenem– Broad spectrum including anaerobes
and Pseudomonas aeruginosa– Parentally administered– Must be combined with cilastatin to be
absorbed– Excreted by kidneys
• Meropenem, ertapenem, and doripenem are similar to imipenem but don’t need co-administration with cilastatin
cilastatin chemical compound which inhibits the human enzyme dehydropeptidase01/23/15 35GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications of Carbapenems
• Nausea and vomiting (common)• Hypersensitivity reactions (uncommon)– Essentially the same as for penicillins– Cross-reactivity is possible
01/23/15 36GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Aztrenam – a monobactam
• Monobactam - beta-lactam compounds wherein the beta-lactam ring is alone and not fused to another ring
• Works only on Gm -ve, including Pseudomonas aeruginosa
• Useful for treating G-ve infections that require a beta-lactam because it does not elicit hypersensitivity reactions
01/23/15 37GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Beta-lactamase inhibitorsa. Clavulanic acid
– Irreversible inhibitor of β-lactamase– Good oral absorption– Combined with amoxicillin or ticarcillin
b. Sulbactam
01/23/15 38GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Peptide AntibioticsPeptide antibiotics are drugs with
polypeptides structureSub-group of Peptide Antibiotics
Polymyxins e.g.»Polymyxin B»Colistin
Glycopeptides e.g.»Vancomycin»Teicoplanin»Avoparcin
BacitracinStreptogramins
Each drug group has its own mechanism of action4 groups and 4 mechanism
01/23/15 39GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
PolymyxinsPolymyxinsDrug members
Polymyxin BColistin (Polymyxin E)
Mechanism of actionDetergent-like actionDamage to cell membrane functionBind to Lipopolysaccharides (LPS) and
destroy outer membrane of Gram-negative bacteria
BactericidalConcentration-dependentNon-selective on bacterial membrane
Spectrum of activityGram-negative bacteria01/23/15 40
GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
PolymyxinsPolymyxins• Pharmacokinetics–Not absorbed via GI tract– If injection, drug accumulated and
slowly excreted• Toxicities–Highly toxic if systemic injection–Nephrotoxic–Neurotoxic
• Clinical uses–Oral treatment–Local treatment
01/23/15 41GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
GlycopeptidesGlycopeptides• Group members–Vancomycin
• Antibacterial activity– Inhibition of cell wall synthesis–Active against Gram-positive bacteria
• Not absorbed orally, must administered IV
• High toxicity–Local irritation , ototoxicity,
nephrotoxicity• Clinical uses–Hardly used in animals–Used only resistant case i.e. to beta-
lactams
01/23/15 42GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
BacitracinBacitracin• Drug activity– Inhibit cell wall synthesis–Activity on Gram-positive bacteria–Bactericidal
• Nephrotoxic if systemic injection• Clinical uses – the same as polymyxin–Oral – as growth promoter–Local or topical drugs
01/23/15 43GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Protein synthesis inhibitors– Aminoglycosides
– Tetracyclins
- Spectinomycin
– Macrolides
– Chloramphenicol
– Clindamycin
01/23/15GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC0245
Inhibition of Protein Synthesis by Antibiotics
Figure 20.401/23/15 46GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Review of Initiation of Protein Synthesis
30S1 32 GTP
1 2 3 GTP
Initiation Factors
mRNA
3
12 GTP
30S Initiation Complex
f-met-tRNA
Spectinomycin
Aminoglycosides
12
GDP + Pi 50S
70S Initiation Complex
AP
01/23/15 47GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Review of Elongation of Protein Synthesis
GTP
AP
Tu GTP Tu GDP
Ts
TsTu
+
GDPTs
Pi
P ATetracycline
AP
Erythromycin
Fusidic Acid
Chloramphenicol
G GTPG GDP + Pi
G
GDP
AP
+GTP
01/23/15 48GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Antimicrobials that Bind to the 30S Ribosomal Subunit
01/23/15 49GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
a) Aminoglycosides (bactericidal)streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, neomycin (topical)
• Mode of action - The aminoglycosides irreversibly bind to the 16S ribosomal RNA and freeze the 30S initiation complex (30S-mRNA-tRNA) so that no further initiation can occur.
• They also slow down protein synthesis that has already initiated and induce misreading of the mRNA. – By binding to the 16 S r-RNA the aminoglycosides increase
the affinity of the A site for t-RNA regardless of the anticodon specificity.
• May also destabilize bacterial membranes.
01/23/15 50GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Microbe Library
American Society for Microbiology
www.microbelibrary.org01/23/15 51
GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
b) Aminoglycosides (bactericidal)streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, neomycin (topical)
• Spectrum of Activity –Effective against many gram-negative and some gram-positive bacteria;
• Not useful for anaerobic (oxygen required for uptake of antibiotic) or intracellular bacteria.
• Resistance - Common• Synergy - The aminoglycosides synergize with β -lactam
antibiotics. The β -lactams inhibit cell wall synthesis and thereby increase the permeability of the aminoglycosides.
01/23/15 52GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
c) Tetracyclines (bacteriostatic)tetracycline, minocycline and doxycycline
• Mode of action - The tetracyclines reversibly bind to the 30S ribosome and inhibit binding of aminoacyl-t-RNA to the acceptor site on the 70S ribosome.
• Spectrum of activity - Broad spectrum; Useful against intracellular bacteria
• Resistance - Common
• Adverse effects - Destruction of normal intestinal flora resulting in increased secondary infections; staining and impairment of the structure of bone and teeth.
01/23/15 53GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
d) Spectinomycin (bacteriostatic)
• Mode of action - Spectinomycin reversibly interferes with m-RNA interaction with the 30S ribosome. It is structurally similar to the aminoglycosides but does not cause misreading of mRNA.
• Spectrum of activity - Used in the treatment of penicillin-resistant Neisseria gonorrhoeae
• Resistance - Rare in Neisseria gonorrhoeae
01/23/15 54GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Antimicrobials that Bind to the 50S Ribosomal Subunit
01/23/15 55GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
a) Chloramphenicol, Lincomycin, Clindamycin (bacteriostatic)
• Mode of action - These antimicrobials bind to the 50S ribosome and inhibit peptidyl transferase activity.
• Spectrum of activity - Chloramphenicol - Broad range;Lincomycin and clindamycin - Restricted range
• Resistance - Common
• Adverse effects - Chloramphenicol is toxic (bone marrow suppression) but is used in the treatment of bacterial meningitis.
01/23/15 56GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
b) Macrolides (bacteriostatic)erythromycin, clarithromycin, azithromycin, spiramycin
• Mode of action - The macrolides inhibit translocation.
• Spectrum of activity - Gram-positive bacteria, Mycoplasma, Legionella
• Resistance - Common
01/23/15 57GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Macrolides : ClassificationMacrolides : Classification• Macrolides are drugs with lactone ring
structure• Sub-groups are based on no. of ring atom– 12-membered ring macrolides– 13-membered– 14-membered (many drugs)– 15-membered– 16-membered (many drugs)
• Special groups– Azalides – name for 15-membered– Triamilides – name for tulathromycin
(combination of 13- and 15-membered)– Ketolides – name for 14-membered with 3
keto group01/23/15 58GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
MacrolidesMacrolidesDrug examples13-membered
Tulathromycin (Triamilides)14-membered
ErythromycinClarithromycin, Roxithromycin,
Dirithromycin15-membered
Azithromycin (Azalides)Tulathromycin (Triamilides)
16-memberedSpiramycinTylosin
01/23/15 59GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Macrolides – general Macrolides – general propertiesproperties
• Mechanism of action– Inhibit protein
synthesis– Bind to 50S
ribosomal unit– Bacteriostatic
• Spectrum of activity– Gram-positive– Some Gram-
negative– Anaerobes–Mycoplasma
01/23/15 60GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Macrolides Macrolides Pharmacokinetics
Broad distribution in body tissues
High intracellular concentration
01/23/15 61GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
MacrolidesMacrolides
Additional properties of Macrolides
• Anti-inflammatory effect– Inhibitory effect on
neutrophils– inhibit
proinflammatory cytokines
– Useful for treatment of inflammatory pulmonary disease
• Prokinetic effect– Stimulate movement
of GI tract
01/23/15 62GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
ErythromycinErythromycin
• Erythromycin is a standard or basic drug of macrolides
• Other drug members are usually compared with erythromycin
• Important adverse effect - severe diarrhea– Especially in adult horse and ruminants
• Clinical uses– Second choice (alternative drug) in
humans– Small animals– Fowls– Some cases in ruminants
01/23/15 63GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Tylosin andTylosin and SpiramycinSpiramycin• Tylosin and Spiramycin– Activities are similar
to erythromycin– Good activity on
Mycoplasma• Examples of Clinical
uses–Whooping couph– Pneumonia– VDs– Used in ruminants
and pigs
01/23/15 64GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Advanced generation Advanced generation MacrolidesMacrolides
Example drugsRoxithromycinDirithromycinClarithromycinAzithromycin
General activity – the same as erythromycinBetter Pharmacokinetic properties
Acid stableFewer GI side effectHigher oral availabilityLonger serum half-livesHigher tissue concentrations
01/23/15 65GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
KetolidesKetolides• Ketolides are 14-
membered ring macrolides with 3 keto group
• Specific drugs– Telithromycin– Cethromycin (still
in clinical study)• Important
properties– Less resistance– Good activities on
bacteria resistant to erythromycin
01/23/15 66GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Fusidic acid (bacteriostatic)
• Selectivity due to differences in prokaryotic and eukaryotic elongation factors
• Mode of action - Fusidic acid binds to elongation factor G (EF-G) and inhibits release of EF-G from the EF-G/GDP complex.
• Spectrum of activity - Gram-positive cocci
01/23/15 67GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC02
Antimicrobials that Interfere with Elongation Factors
Inhibitors of Nucleic Acid Synthesis
~Inhibitors of DNA synthesis~Inhibitors of RNA synthesis
01/23/15 69GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Inhibitors of RNA SynthesisFor this class of antibiotics, selectivity is due to differences between prokaryotic and eukaryotic RNA polymerase i.e.
All RNA polymerases are multi-protein complexes, however, the number of proteins that are assembled to form the active enzyme is much larger in eukaryotes;
•The basic catalytic core is made up of 12 subunits.
•By comparison, bacterial RNAP has 5 subunits.
01/23/15 70GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Rifampin, Rifamycin, Rifampicin, Rifabutin (bactericidal)
• Mode of action - These antimicrobials bind to DNA-dependent RNA polymerase and inhibit initiation of mRNA synthesis.
• Spectrum of activity - Broad spectrum but is used most commonly in the treatment of tuberculosis
• Resistance – Common– For example; – Resistance to rifampicin develops quickly during treatment, so
monotherapy should not be used to treat these infections — it should be used in combination with other antibiotics.
– Resistance to rifampicin arises from mutations that alter residues of the rifampicin binding site on RNA polymerase, resulting in decreased affinity for rifampicin.
• Combination therapy - Since resistance is common, rifampin is usually used in combination therapy.
01/23/15 71GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Inhibitors of DNA SynthesisFor this class of antibiotics, selectivity due to differences between prokaryotic and eukaryotic DNA replication enzymes
Consider the following:
Eukaryotic replication is more complicated. •First, they have multiple ori per chromosome that allow for bidirectional synthesis of the linear chromosome. •They also use several DNA polymerases (I, II, III), and ligase (seals the nicks in the DNA strand), and RNA primer (gives a 3' end for the DNA polymerase to start synthesis).
•As for other differences in their synthesis of DNA is their speed, prokaryotes can replicate their chromosome at about 1,000 bp/sec, while eukaryotes can replicate their chromosomes at about 100 bp/sec. •They also differ in the number of ori, eukaryotes (as it was stated above) has multiple ori, while prokaryotes have only one.
01/23/15 72GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
The Quinolones
• Current drugs are fluoridated 4-quinolones
• Broad coverage (some broader than others)
• Targets DNA gyrase ( G-) and topoisomerase IV (G+)
• Resistance due to efflux and mutations in targets
01/23/15 73GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Pharmacological attributes of Quinolones• Favorable pharmacological attributes– Orally administered, quickly absorbed,
even with a full stomach– Excellent bioavailability in a wide
range of tissues and body fluids (including inside cells)
• Mostly cleared by the kidneys– Exceptions are pefloxacin and
moxifloxacin which are metabolized by liver
• Ciprofloxacin, ofloxacin, and pefloxacin are excreted in breast milk
““Got Cipro?”Got Cipro?”
01/23/15 74GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Therapeutic Uses of Quinolones
• Urinary tract infections
• Prostatitis• STD’s– Chlamydia– Chancroid - painful
sores on the genitalia– Not syphilis or
gonorrhea (due to increased resistance)
01/23/15 75GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Therapeutic Uses of Quinolones
• GI and abdominal – Travelers diarrhea– Shigellosis– Typhoid fever
• Respiratory tract– New agents for strep. pneumonia
01/23/15 76GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Therapeutic Uses of Quinolones
• Bone, joint, soft tissue– Ideal for chronic
osteomylitis - infection of the bone or bone marrow• Resistance developing in
S. aureus, P. aeruginosa, and S. marcesens
– Good against polymicrobial infections like diabetic foot ulcers
01/23/15 77GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Therapeutic Uses of Quinolones
• Ciprofloxacin for anthrax and tuleremia (rabbit fever, deer fly fever, Ohara's fever)
• Combined with other drugs, useful for atypical Mycobacterium sp.
Pulmonary AnthraxPulmonary Anthrax
01/23/15 78GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications of Quinolones• Nausea, vomiting, abdominal discomfort (common)• Diarrhea and antibiotic-associated colitis (uncommon to rare)• CNS side effects
– Mild headache and dizziness (common to rare)– Hallucinations, delirium, and seizures (rare)
• Arthropy in immature animals (common)– Quinolones not given to children unless benefits outweigh the risks
• Leukopenia, eosinophilia, heart arythmias (rare)
delirium - disorder involving incoherent speech, hallucinations, etc., caused by intoxication, fever, etc
01/23/15 79GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Inhibitors of Folic Acid Synthesis
• Basis of Selectivity• Review of Folic
Acid Metabolism
p-aminobenzoic acid + Pteridine
Dihydropteroic acid
Dihydrofolic acid
Tetrahydrofolic acid
Pteridine synthetase
Dihydrofolate synthetase
Dihydrofolate reductase
ThymidinePurines
Methionine
Trimethoprim
Sulfonamides
01/23/15 81GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Sulfonamides, Sulfones (bacteriostatic)
• Mode of action - These antimicrobials are analogues of para-aminobenzoic acid and competitively inhibit formation of dihydropteroic acid.
• Spectrum of activity - Broad range activity against gram-positive and gram-negative bacteria; used primarily in urinary tract and Nocardia infections.
• Resistance - Common• Combination therapy - The sulfonamides are used in
combination with trimethoprim; this combination blocks two distinct steps in folic acid metabolism and prevents the emergence of resistant strains.
01/23/15 82GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Trimethoprim, Methotrexate, Pyrimethamine (bacteriostatic)
• Mode of action - These antimicrobials binds to dihydrofolate reductase and inhibit formation of tetrahydrofolic acid.
• Spectrum of activity - Broad range activity against gram-positive and gram-negative bacteria; used primarily in urinary tract and Nocardia infections.
• Resistance - Common• Combination therapy - These antimicrobials are used in
combination with the sulfonamides; this combination blocks two distinct steps in folic acid metabolism and prevents the emergence of resistant strains.
01/23/15 83GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Sulfonamides
• Analogues of para-aminobenzoic acid
• Broad spectrum• Competitive inhibitors of
dihydropteroate synthase – needed for folic acid synthesis
Gerhard Domagk gets a Nobel Gerhard Domagk gets a Nobel for Medicine, 1939.for Medicine, 1939.
01/23/15 84GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Sulfonamides• Mostly absorbed from GI tract• Binds variably to serum albumin • Wide tissue distribution, including
transplacentally• Variably inactivated in liver by
acetylation and then excreted in urine
• Some agents can precipitate in acid urine
01/23/15 85GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
1. Rapidly Absorbed and Eliminated Sulfonamides
• Sulfisoxazole, sulfamethoxazole, sulfadiazine
• Bind extensively to plasma proteins
• Highly concentrated in urine (cidal)
• Sulfamethoxazole combined with trimethoprim (Bactrim) is widely used to treat a variety of infections (esp. UTI)
01/23/15 86GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
2. Poorly Absorbed Sulfonamides
• E.g. Sulfasalazine• Poorly absorbed in GI tract• Used to treat ulcerative colitis
and irritable bowel syndrome• Gut flora metabolize drug into
2 compounds, 1 toxic- sulfapyridine, 1 therapeutic (5-aminosalicylate)
• Hence is a prodrug – effective after breakdown
Ulcerative Colitis
01/23/15 87GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Sulfonamides for Topical Use
• E.g. 1.Sulfacetamide– Good penetration in eye
– Non-irritating
• 2. Silver sulfadiazine– Prevention and treatment of
burn wound infections
Bacterial corneal infectionBacterial corneal infection
01/23/15 88GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Long Acting Sulfonamide
• Serum half-life is measured in days rather than minutes or hours
• E.g. Sulfadoxine
• Combined with pyirethamine to treat malaria
Plasmodium vivaxPlasmodium vivax
01/23/15 89GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Therapeutic Uses of Sulfonamides
• Urinary tract infections• Nocardiosis -serious infection
caused by a fungus-like bacterium that begins in the lungs and can spread to the brain.
• Toxoplasmosis - caused by protozoan (avoid using in pregnant women)
Nocardia asteroidesNocardia asteroides
01/23/15 90GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications of Sulfonamides - UT
• Crystallization in acid urine– Common to uncommon
depending on drug.
– Alkalize urine or increase hydration
01/23/15 91GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications of Sulfonamides - blood
• Acute hemolytic anemia – Rare to extremely rare
– Associated with glucose-6-phosphate dehydrogenase activity in RBC
• Agranulocytosis - failure of the bone marrow to make enough white
blood cells (neutrophils). (extremely rare)
• Aplastic anemia - marrow doesn't make enough new blood cells.
(extremely rare)
01/23/15 92GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications of Sulfonamides - immune
• Hypersensitivity reactions (common to uncommon)– Skin and mucous membrane
manifestations (rashes)– Serum sickness - type III hypersensitivity
reaction that results from the injection of heterologous or foreign protein or serum
– Focal or diffuse necrosis of the liver (rare)
01/23/15 93GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
Toxicity/Contraindications of Sulfonamides - miscellaneous
• Nausea, anorexia, vomiting (common)
• Kernicterus; damage caused by excessive jaundice– Displacement of bilirubin from
plasma albumin to brain resulting in encephalopathy(disease of the brain)
– Never give sulfa drugs to a pregnant or lactating woman
• Potentiation of oral coagulants, sulfonylurea hypoglycemic drugs, and hydrantoin anticonvulsants
Bilirubin deposits in neonatal Bilirubin deposits in neonatal brainbrain
01/23/15 95GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC02
INJURY TO THE PLASMA MEMBRANE - Brief
• All cells are bound by a cell membrane. • And although the membranes of all cells are quite
similar, those of bacteria and fungi differ from eukaryotic cells.
• These slight differences allow for selective action of some antimicrobial agents.
• Certain antibiotics, like polymyxins, act as detergents to dissolve bacterial cell membranes by binding to phospholipids present in the membranes.
01/23/15GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC0296